The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American ...

Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

In a report released on April 9, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly and ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Experts concerned over promotional strategies of Eli Lilly for tirzepatide: Shardul Nautiyal, Mumbai Friday, April 11, 2025, 08:00 Hrs [IST] As Mounjaro (tirzepatide), the blockbu ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

A woman felt like she was being "ripped open by a knife" after suffering extreme reaction to single weight loss jab Mounjaro.

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...